Results 171 to 180 of about 34,696 (251)

Challenges in tracer development for tumor microenvironment (TME) imaging. [PDF]

Eur J Nucl Med Mol Imaging
Martin S, Wendlinger L, Koch H, Lopez-Martinez I, Corsanici G, Battistini G, Bonvin Y, Delage J, Viertl D, Faizova R, Litvinenko A, Schottelius M.   +11 more
europepmc   +1 more source

Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer. [PDF]

J Nucl Med
Klauser PC, Dehlavi G, De Franco M, Loor A, Viray T, Michel A, Qeriqi B, de Stanchina E, Carter LM, Carrasco SE, Zeglis BM, Janjigian YY, Lewis JS.   +12 more
europepmc   +1 more source

CD70-targeted platform for diagnosing and treating multiple myeloma. [PDF]

J Immunother Cancer
Li J, Yan H, Wang X, Zhang Y, Chen P, Feng J, Zhang R, Li Z, Huang Z, Xu C, Ma N, Lin X, Zhao M, Zhu W, Peng Q, Xie S, Wei W, Dong M.   +17 more
europepmc   +1 more source

PET Imaging in Alzheimer Disease in the Era of Antiamyloid Therapy in the United States: Clinical Utility, Quantification, and Policy Landscape. [PDF]

J Nucl Med Technol
Skyles T, Bouchal SM, Giarratana A, Wengler J, Hart I, Greig E, Singh H, Huang SS, Martinez F, Nguyen B, Shin CH, Yang M, Parent E, Robb WH, Franceschi AM, Burkett B, Johnson D, Koran ME.   +17 more
europepmc   +1 more source

Tumour Microenvironment-Informed Radiotheranostics: Why and How Nuclear Medicine Could Advance Precision Oncology in the Decade Ahead. [PDF]

Pharmaceuticals (Basel)
Pandya K, Lin Z, Wadsak M, Wang J, Shi K, Seifert R.   +5 more
europepmc   +1 more source

Availability of Radiopharmaceuticals and Imaging Equipment in English-Speaking African Countries. [PDF]

J Nucl Med Technol
Mosima LS, Manicum AE, Summers B.
europepmc   +1 more source

PET Radiopharmaceuticals.

Iranian journal of pharmaceutical research : IJPR, 2011
openaire   +2 more sources

Influence of Peptide-Based Chelator Sequences on HER2-Targeting Radiopeptide. [PDF]

J Pept Sci
Gupta S, Kumar M, Repaka KM, Das A, Kengar AA, Satpati D.   +5 more
europepmc   +1 more source

How Regulation 536/2014 Is Changing Academic Research with Therapeutic Radiopharmaceuticals: A Local Experience. [PDF]

Pharmaceuticals (Basel)
Di Iorio V, Boschi S, Brugugnoli E, Sansovini M, Matteucci F, Masini C, Monti M.   +6 more
europepmc   +1 more source

Fluorination augments tumor engagement and antitumor immunity of a D-peptide-based radiotheranostic agent for combinatorial immune checkpoint blockade therapy. [PDF]

J Immunother Cancer
Zhang S, Liu C, Lu Q, Liu W, Wu J, Liu J, Tong L, Zhao K, Hu Q, Chen X, Li L, Song X, Wang F, Dai D, Wang R, Hu K.   +15 more
europepmc   +1 more source